KUALA LUMPUR, Nov 6 (Bernama) -- Biotech company, ArrayPatch Ltd (ArrayPatch) has completed the second close of its seed financing round, securing an additional 1.6 million euros, bringing the total raised to 3.2 million euros, as it develops skin patches that deliver medicine through tiny dissolving needles. (1 Euro = RM4.54)
ArrayPatch Raises 3.2 Mln Euros For Diabetes, Obesity Microneedle Patch
ArrayPatch Raises 3.2 Mln Euros For Diabetes, Obes
BE Bernama 
Key takeaways
ArrayPatch raised 3.2 million euros in seed funding to develop dissolving microneedle patches for treating obesity, diabetes, and basal cell carcinoma. The company aims to advance its DerMap platform toward first human trials.
- The second close secured 1.6 million euros, co-led by WakeUp Capital, bringing total seed funding to 3.2 million euros.
- Funds will support the DerMap platform's progression to initial human trials for obesity, diabetes, and skin cancer.
- The technology uses microneedles made entirely of medicine, eliminating polymers and enabling higher drug delivery capacity.
Summarised automatically by AI from the original article by Bernama. AI can make mistakes, so check the original for details.
Read the full story on Bernama That's the opening of the story. The full piece is published by Bernama.
Continue reading ↗ Story details
- Published
- Section
- news
- Format
- Article
- Original
- bernama.com ↗
%2Ffile%2Fpublisher-c1a3f893382d2b2f8a9aa22a654d9c97%2F2024%2F10%2Fd9bd3941b3b8130c20f96f0699539ec7.jpg&w=480&output=webp&q=85&we)